178
Views
7
CrossRef citations to date
0
Altmetric
Original Article

The effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin

, , , , , , , , , , , , & show all
Pages 495-503 | Received 12 Feb 2011, Accepted 19 Feb 2011, Published online: 12 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Pieter-Jan De Kam, Wen-Lin Luo, Larissa Wenning, Lisa Ratcliffe, Christine McCrary Sisk, Jane Royalty, Waldemar Radziszewski, John A. Wagner & Eseng Lai. (2014) The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin. Platelets 25:7, pages 480-487.
Read now
Rahul Yadav, Michael France, Naveed Younis, Salam Hama, Basil J Ammori, See Kwok & Handrean Soran. (2012) Extended-release niacin with laropiprant: a review on efficacy, clinical effectiveness and safety. Expert Opinion on Pharmacotherapy 13:9, pages 1345-1362.
Read now
Rahul Yadav, See Kwok, Basil J. Ammori, Basil Issa & Handrean Soran. (2012) Safety and tolerability of extended-release niacin with laropiprant. Expert Opinion on Drug Safety 11:1, pages 151-159.
Read now

Articles from other publishers (4)

Deping Kong, Juanjuan Li, Yujun Shen, Guizhu Liu, Shengkai Zuo, Bo Tao, Yong Ji, Ankang Lu, Michael Lazarus, Richard M. Breyer & Ying Yu. (2017) Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D 2 Receptor Subtype 1 . Journal of Pharmacology and Experimental Therapeutics 360:3, pages 435-444.
Crossref
Richard L. Dunbar & Harsh Goel. (2016) Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part I: Alternative Niacin Regimens. Current Atherosclerosis Reports 18:2.
Crossref
Rahul Yadav, Yifen Liu, See Kwok, Salam Hama, Michael France, Ruth Eatough, Phil Pemberton, Jonathan Schofield, Tarza J. Siahmansur, Rayaz Malik, Basil A. Ammori, Basil Issa, Naveed Younis, Rachelle Donn, Adam Stevens, Paul Durrington & Handrean Soran. (2015) Effect of Extended‐Release Niacin on High‐Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin‐Treated Patients. Journal of the American Heart Association 4:9.
Crossref
. (2014) Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients. New England Journal of Medicine 371:3, pages 203-212.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.